Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.
about
Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes.Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
P2860
Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@en
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@nl
type
label
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@en
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@nl
prefLabel
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@en
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@nl
P2093
P2860
P50
P356
P1476
Plasma Fibroblast Growth Facto ...... in the Framingham Heart Study.
@en
P2093
Danielle Enserro
Gary F Mitchell
Matthias Nauck
Naomi M Hamburg
P2860
P356
10.1161/JAHA.116.003486
P50
P577
2016-07-06T00:00:00Z